Evogene Ltd. (TLV: EVGN)
Israel
· Delayed Price · Currency is ILS · Price in ILA666.00
+18.20 (2.81%)
Nov 19, 2024, 3:56 PM IDT
Evogene Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 9.45 | 5.64 | 1.68 | 0.93 | 1.04 | 0.75 | Upgrade
|
| Revenue Growth (YoY) | 290.29% | 236.72% | 80.11% | -10.58% | 38.11% | -56.90% | Upgrade
|
| Cost of Revenue | 1.76 | 1.69 | 0.91 | 0.77 | 0.57 | 0.33 | Upgrade
|
| Gross Profit | 7.69 | 3.95 | 0.77 | 0.16 | 0.47 | 0.42 | Upgrade
|
| Selling, General & Admin | 9.74 | 9.68 | 10.42 | 9.99 | 7.99 | 5.79 | Upgrade
|
| Research & Development | 19.43 | 20.78 | 20.79 | 21.13 | 17.29 | 15.79 | Upgrade
|
| Other Operating Expenses | - | - | -3.5 | - | - | - | Upgrade
|
| Operating Expenses | 29.17 | 30.46 | 27.71 | 31.12 | 25.28 | 21.59 | Upgrade
|
| Operating Income | -21.48 | -26.51 | -26.94 | -30.95 | -24.81 | -21.17 | Upgrade
|
| Interest Expense | - | -0.12 | -0.17 | -0.32 | -0.24 | -0.3 | Upgrade
|
| Interest & Investment Income | 1.6 | 1.25 | 0.18 | 0.29 | 0.23 | 0.76 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.25 | -0.25 | -1.74 | 1.07 | 1.01 | 1.27 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.16 | -0.16 | -0.25 | -0.46 | -2.33 | -0.09 | Upgrade
|
| EBT Excluding Unusual Items | -20.3 | -25.78 | -28.92 | -30.37 | -26.14 | -19.53 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.05 | 0.05 | -0.72 | -0.06 | -0.03 | 0.44 | Upgrade
|
| Other Unusual Items | -0.25 | -0.25 | -0.11 | - | - | - | Upgrade
|
| Pretax Income | -21.03 | -25.99 | -29.75 | -30.43 | -26.17 | -19.09 | Upgrade
|
| Income Tax Expense | -0.01 | -0.03 | 0.09 | 0.01 | 0.03 | 0.02 | Upgrade
|
| Earnings From Continuing Operations | -21.03 | -25.95 | -29.84 | -30.45 | -26.21 | -19.12 | Upgrade
|
| Minority Interest in Earnings | 1.16 | 2.08 | 3.21 | 2.65 | 2.83 | 1 | Upgrade
|
| Net Income | -19.87 | -23.88 | -26.64 | -27.79 | -23.37 | -18.11 | Upgrade
|
| Net Income to Common | -19.87 | -23.88 | -26.64 | -27.79 | -23.37 | -18.11 | Upgrade
|
| Shares Outstanding (Basic) | 5 | 5 | 4 | 4 | 3 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 5 | 5 | 4 | 4 | 3 | 3 | Upgrade
|
| Shares Change (YoY) | 21.04% | 10.86% | 1.92% | 43.59% | 9.34% | 0.00% | Upgrade
|
| EPS (Basic) | -3.95 | -5.23 | -6.46 | -6.87 | -8.30 | -7.03 | Upgrade
|
| EPS (Diluted) | -3.95 | -5.23 | -6.46 | -6.87 | -8.30 | -7.03 | Upgrade
|
| Free Cash Flow | -20.28 | -22.36 | -24.85 | -25.56 | -20.2 | -18.57 | Upgrade
|
| Free Cash Flow Per Share | -4.04 | -4.89 | -6.03 | -6.32 | -7.17 | -7.21 | Upgrade
|
| Gross Margin | 81.42% | 70.00% | 45.73% | 17.53% | 44.81% | 55.64% | Upgrade
|
| Operating Margin | -227.27% | -470.00% | -1608.42% | -3328.28% | -2385.96% | -2810.89% | Upgrade
|
| Profit Margin | -210.26% | -423.39% | -1590.33% | -2988.49% | -2247.50% | -2405.31% | Upgrade
|
| Free Cash Flow Margin | -214.64% | -396.49% | -1483.52% | -2748.71% | -1941.92% | -2465.60% | Upgrade
|
| EBITDA | -19.67 | -24.7 | -25.09 | -28.72 | -22.09 | -18.4 | Upgrade
|
| EBITDA Margin | -208.19% | - | - | - | - | - | Upgrade
|
| D&A For EBITDA | 1.8 | 1.81 | 1.85 | 2.23 | 2.73 | 2.77 | Upgrade
|
| EBIT | -21.48 | -26.51 | -26.94 | -30.95 | -24.81 | -21.17 | Upgrade
|
| EBIT Margin | -227.27% | - | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.